Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
ASX:NVO

Novo Resources (NVO) Stock Price, News & Analysis

→ Boost your retirement with these AI payouts (From InvestorPlace) (Ad)
Free NVO Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
NVO stock logo

About Novo Resources Stock (ASX:NVO)

Novo Resources Corp., together with its subsidiaries, engages in evaluating, acquiring, exploring, and developing natural resource properties in Canada, Australia, and the United States. The company primarily explores for gold deposits. It holds approximately 7,500 sq km of land in the Pilbara region of Western Australia, as well as interests in various projects located in Victoria, Australia. The company was formerly known as Galliard Resources Corp. and changed its name to Novo Resources Corp. in June 2011. Novo Resources Corp. was incorporated in 2009 and is headquartered in Vancouver, Canada.

NVO Stock News Headlines

May 18 at 6:23 PM | msn.com
Novo Nordisk, J&J lead R&D rankings in big pharma: report
May 18 at 2:44 AM | msn.com
Is Novo Nordisk Stock a Millionaire Maker?
May 16, 2024 | msn.com
Novo Nordisk falls on reports of fire at construction site (update)
May 16, 2024 | finance.yahoo.com
Novo Resources Announces Change of Auditor
May 6, 2024 | ca.finance.yahoo.com
Canadian Investment Regulatory Organization Trading Halt - NVO.WT.A
May 6, 2024 | msn.com
Gates, Novo Nordisk And Wellcome Commit $300 Million To Climate Change, Infectious Diseases And Nutrition
May 4, 2024 | theglobeandmail.com
Novo Resources: Top 10 Undervalued Growth Stocks on TSX (NVO)
May 2, 2024 | morningstar.com
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
May 2, 2024 | msn.com
Novo Nordisk Investing $6 Billion to Increase Access to Ozempic and Wegovy amid Nationwide Shortage
May 2, 2024 | seekingalpha.com
Wall Street Breakfast: As It May
May 2, 2024 | msn.com
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
May 2, 2024 | msn.com
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
May 2, 2024 | msn.com
Novo Nordisk Lifts Guidance as Blockbuster Drug Demand Shows No Signs of Abating
May 2, 2024 | marketwatch.com
Novo Nordisk Raises FY Sales and Op Profit Guidance
May 2, 2024 | money.usnews.com
Obesity Drugmaker Novo Nordisk Raises Outlook, Q1 Profit Beats Forecast
May 1, 2024 | nytimes.com
Getir, a Rapid Grocery-Delivery Service, Exits the U.S. and Europe
April 29, 2024 | msn.com
Ancient ‘Paleo’ diet largely consisted of plants for some hunter-gatherers, study finds
April 29, 2024 | marketwatch.com
Novo Nordisk Earnings Expected to Rise Further, With Production in Focus -- Earnings Preview
April 26, 2024 | marketwatch.com
Novo Nordisk Probed by Senate Committee on Weight-Loss Drug Prices
April 24, 2024 | seekingalpha.com
Novo Nordisk comes under Senate probe over pricing for weight loss drugs
April 23, 2024 | msn.com
Compare with FTSE Novo-Nordisk B Index (SSNOVO)
April 20, 2024 | nytimes.com
Inside Novo Nordisk’s Headquarters
April 17, 2024 | msn.com
Ozempic isn't linked to suicidal thoughts, U.S. and European health agencies find
April 17, 2024 | msn.com
Healthy Returns: U.S. drug shortages reach record high, hitting Wegovy, ADHD medications
April 17, 2024 | theglobeandmail.com
Internships, youth programs key to developing the next generation of talent
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Basic Materials
Industry
Gold
Sub-Industry
N/A
Current Symbol
ASX:NVO
CUSIP
N/A
CIK
N/A
Web
www.nvoi.com.au
Phone
1300 687 179
Fax
N/A
Employees
75
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-48,890,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-35.83%
Return on Assets
-13.65%

Debt

Debt-to-Equity Ratio
1.90
Current Ratio
2.66
Quick Ratio
4.30

Sales & Book Value

Annual Sales
$2.50 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
2.25
Book Value
A$0.24 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
354,630,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.52

Key Executives

  • Mr. Michael John Spreadborough MBA
    Executive Co-Chairman & Acting CEO
  • Ms. Karen De Luca
    General Manager of Exploration
  • Ms. Elza van der Walt
    CFO & Joint Corporate Secretary
  • Ms. Lisa Smith
    General Counsel & Joint Corporate Secretary
  • Mr. Alwin van Roij
    Senior Exploration Geologist

Key Competitors

View All Competitors

This page (ASX:NVO) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
Warren Buffett's "mystery stock"
Stansberry Research
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest
Elon to Transform U.S. Economy?
Porter & Company